RecruitingPhase 2NCT07543120
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Sponsor: Novartis Pharmaceuticals
Jefferson City, MO · +18 more sites
1 recruiting hypertension studies with a site in Jefferson City, MO.
Sponsor: Novartis Pharmaceuticals
Jefferson City, MO · +18 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.